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A breakdown in homeostasis of redox-active metals represents an important factor for
neurodegeneration. We have used EPR spectroscopy and BMPO spin-trap to investigate the
catalytic properties and ligand modulation of redox activity of copper and iron in human
cerebrospinal fluid (CSF). In contrast to iron, copper supplementation provoked a statistically
significant increase in hydroxyl free radical generation in CSF treated with H2O2. However, in a
binary copper/iron containing Fenton system, iron catalytically activated copper. The chelator
EDTA, which represents a model of physiological metal ligands, completely prevented copper’s
redox activity in CSF, while iron chelation led to a significant increase in hydroxyl radical
generation, indicating that copper and iron do not only have diverse catalytic properties in the CSF
but also that their redox activities are differently modulated by ligands. The application of DDC
reduced hydroxyl radical generation in the CSF containing catalytically active metals (free Cu2+ or
Fe3+-EDTA complex). We conclude that chelators, such as DDC, are capable of preventing the pro-
oxidative activity of both metals and may be suitable for reducing hydroxyl radical formation in
certain pathophysiological settings.
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Introduction
A low level of antioxidants and low regenerative capacity
in combination with high oxygen consumption together
result in brain tissue being susceptible to oxidative
damage.1 The most detrimental pro-oxidative process is
the Fenton reaction allowing H2O2-mediated oxidation of
redox-active metals such as iron and copper producing
highly reactive HO• radical.2,3 In contrast to the cytosol
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Abbreviations: EPR, electron paramagnetic resonance; BMPO, 5-tert-
butoxycarbonyl 5-methyl-1-pyrroline N-oxide; CSF, cerebrospinal fluid;
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ALS, amyotrophic lateral sclerosis
and other body fluids, CSF contains catalytically
active iron and copper as well as small molecular
weight ligands which may catalyse the formation of
HO•. CSF is poor in antioxidants, transferrin and
ceruloplasmin which normally bind and isolate
transition metals. Nervous tissue spontaneously
generates and releases H2O2 into the CSF where, even
under physiological conditions, its concentration can
reach up to 1 mM, while in neurodegeneration H2O2
production is promoted via several different
pathways.4–6 Such characteristics make CSF highly
susceptible to Fenton chemistry.
The levels of copper and iron in brain tissue
increase with age.7 Therefore, a breakdown in metal
homeostasis could represent a key factor in the
promotion of oxidative stress8 related to a variety of
age-related neurodegenerative diseases.9 Extensive
data in the literature show that copper and/or iron
play a significant role in the development of
Alzheimer’s disease, Parkinson’s disease, amyotrophic
lateral sclerosis (ALS) and other neurodegenerative
diseases.8,10 Alzheimer’s disease is characterised by the
appearance of amyloid plaques,11 which could be
described as metallic sinks as unusually high
concentrations of iron (1 mM) and copper (0.4 mM)
have been found within them.1 Amyloid β-peptide is
capable of reducing iron and copper to their
oxidatively active forms (Fe2+ and Cu+) which promote
the Fenton reaction.12 In Parkinson’s disease, iron
deposits have been observed in substantia nigra.13 The
cells that contain neuromelanin, which has been
postulated to be an iron-storage molecule, are most
likely to be lost first due to oxidative damage.14 In
addition, it is known that neuromelanin primarily
consists of products of dopamine redox chemistry, the
most abundant neurotransmitter.15 Dopamine co-
ordinates metals such as Cu2+ and Fe3+,16 reduces the
oxidation state of metals and subsequently causes
H2O2 production,
17 setting up the conditions for
Fenton chemistry. It has also been shown in several
MRI studies that the motor cortex of ALS patients
contains regions of accumulated ferric ions.18 About
20% of familial ALS cases are characterised by
mutations resulting in misfolded Cu,Zn-superoxide
dismutase which may form copper-rich deposits in the
brain.19 The increased level of copper observed in the
CSF of Parkinson’s disease, Alzheimer’s disease4 and
ALS patients19 demonstrates that this metal leaks
from brain deposits into the CSF. This appears not to
be the case for iron since its oxidised form (Fe3+),
preferentially produced under physiological pH
values, readily forms insoluble complexes with
hydroxyl and phosphate ions present in the CSF. It
was observed in environmental studies that reduced
copper transfers an electron to iron which, in turn,
participates in the oxidation of organic compounds in
atmospheric waters.20 Buettner and Jurkiewicz21 have
postulated that such processes may be of significance
in a biological setting. For example, the production of
HO• in the CSF of ALS patients5,22 appears to be
higher than that attributable only to the increased level
of catalytically active copper.19
The aim of this study was to elucidate the
differences between the catalytic properties of copper
and iron in the Fenton system in CSF. As chelation
can modify the redox activity of transition metals, we
have also examined the effects of ligands on HO•
generation in the Fenton system in CSF using EDTA
and DDC as model compounds. EPR spectroscopy
and spin-trap BMPO were used to quantify the
production of HO• radicals in the CSF systems
containing H2O2, iron and copper with or without
EDTA and DDC.
Subjects and methods
CSF samples
Lumbar CSF was obtained from a group of 10
patients with neurological disorders unrelated to
oxidative stress (2 migraines, 3 tension headaches, 3
lumbar disc herniations and 2 cervical disc
herniations). The age range of this group of patients
was 32–59 years (6 males and 4 females). The CSF
samples were obtained after an overnight bed rest and
fasting (at the point when diagnosis took place). CSF
not used for clinical evaluations was used for our
study. CSF was centrifuged (5000 g, 10 min at 4ºC),
rapidly frozen and stored at –80ºC. All patients
received a balanced diet prescribed by a nutritionist
without any vitamin supplements. The recruitment
and counselling of patients, sample collection and
sample handling were all conducted according to the
internationally recognised ethical standards (The
Helsinki Declaration of 1964, as revised in 1975, 1983,
and 1989). Institutional approval for the study was
granted by ‘The Clinics Ethics Committee’ which
followed international guidelines.
Fenton system in CSF
FeCl3 and CuCl2 (Merck, Darmstadt, Germany) were
added to CSF at final concentrations of 10 µM or 100
µM. In all experiments, H2O2 (Renal, Budapest,
Hungary) was added at a final concentration of 1
mM. The system with no supplemented metals served
as a control. The experiments with 100 µM metals
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were repeated in the presence of EDTA (Merck; 100
µM final concentration) which was added to the initial
solutions of metal salts. The effect of DDC (Merck;
500 µM final concentration) on the production of HO•
was determined in two systems: Cu2+ (100 µM) +H2O2
(1 mM) and Fe3+-EDTA (100 µM) + H2O2 (1 mM).
Experiments using the binary catalytic system
(Cu2+/Fe3+) were performed by combining Cu2+ (100
µM), Fe3+ (300 µM) and H2O2 (1 mM) in CSF. All
initial solutions were prepared in ultrapure 18 MΩ
water. All experiments were performed using CSF
from all 10 patients involved in the study. The
concentration of spin-trap BMPO (Northwest LSS;
Vancouver, WA, USA) in all experiments was 500 mM.
EPR spectroscopy
EPR spectra were recorded at room temperature
using a Varian E104-A EPR spectrometer operating
at X-band (9.572 GHz) using the following settings:
modulation amplitude, 2 G; modulation frequency,
100 kHz; and microwave power, 10 mW. The spectra
were recorded using EW software (Scientific
Software, Bloomington, IL, USA). In order to
maintain a constant level of oxygen, samples were
drawn into 10-cm long gas-permeable Teflon tubes
(wall thickness 0.025 mm and internal diameter 0.6 mm;
Zeus Industries, Raritan, NJ, USA), which were placed
in quartz capillaries. Computer simulations of EPR
spectra were performed using the WINEPR SimFonia
computer program (Bruker Analytische Messtechnik
GmbH, Karlsruhe, Germany) in order to identify
BMPO adducts formed in the system and to determine
the intensity of EPR spectra. Simulation parameters for
the spectrum of the BMPO adduct with HO•
(BMPO/OH) were: diastereomer 1 (81.6%): aN = 13.56;
aHβ = 12.3; aHγ = 0.66: diastereomer 2 (18.4%): aN =
13.47; aHβ = 15.31; aHγ = 0.62.
Simulation parameters for the signal of BMPO
adduct with carbon-centred radical (BMPO/C) were:
aN = 15.2 G; aHβ = 21.6 G.23
Statistical analysis
Statistical analysis was carried out using Statistica
v.6.0 (StatSoft Inc.; Tulsa, OK, USA). The results are
presented as mean values (of 10 experiments) ± SD.
Statistical significance was determined using a non-
parametric two-tailed Mann–Whitney test to compare
data pairs (P < 0.05).
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Figure 1 Characteristic EPR spectra of BMPO adducts in the CSF with: (A) Cu2+ (10 µM) and H2O2 (1 mM); (B) H2O2 (1 mM); (C)
Fe3+ (10 µM) and H2O2 (1 mM). Grey: the spectral simulation of BMPO/OH signal. The centre of the signal of BMPO/OH
is at g = 2.0056. Each spectrum represents an accumulation of five spectra obtained using different CSF samples
Results
Characteristic EPR signals (5 accumulations) of
BMPO adducts obtained in CSF after the addition of
1 mM H2O2 with or without pre-added 10 µM redox-
active metals is shown in Figure 1. The spectral
simulation of BMPO/OH adduct was used to identify
the presence of HO• in the systems. The addition of
iron did not lead to increased generation of HO•.
However, supplementation of copper provoked a
statistically significant increase in HO• production
when compared to CSF with only H2O2 added.
In order to distinguish the effects of copper and
iron, experiments were repeated using a higher final
cation concentration (100 µM) (Fig. 2). Even at the
high concentration, Fe3+ supplementation did not
provoke any significant effects. However, 100 µM Cu2+
led to a further increase in HO• production. The
spectral simulation represents a combination of
signals of BMPO/OH and BMPO/C adducts. The
carbon-centred radical could be generated by the
reactions of HO• with proteins or carbonate anions
present in CSF (HO• + CO3
2–→ OH– + CO3
•–).
The chelating agent EDTA caused opposing effects
on HO• generation in the copper-and the iron-based
Fenton systems (Fig. 3A,B). EDTA completely
prevented the activity of copper in the Fenton system
as no BMPO/OH adduct signals were observed. In
contrast, EDTA-mediated chelation of iron (Fe3+-
EDTA) led to a significant increase in the generation
of HO• when compared with the Fenton system
containing iron (Fe3+). DDC was a very efficient
antioxidant as it prevented the generation of HO• in the
CSF with pre-added Cu2+ or Fe3+-EDTA (Fig. 3C,D).
The intensities of BMPO/OH signals obtained in
the systems with 100 µM metals and/or 1 mM H2O2
are shown in Figure 4. In addition, the intensity of the
BMPO/OH signal obtained in the binary system
which simulated the real copper/iron ratio in CSF
(approximately 1:3),24 containing Cu2+ (100 µM), Fe3+
(300 µM) and H2O2 (1 mM) is presented (spectrum not
shown). Iron, which by itself  does not provoke
increased generation of HO•, catalytically activated
copper in the CSF as the level of HO• produced in the
binary copper/iron system was significantly higher
than in the CSF supplemented only with copper (P =
0.011).
Discussion
The sole addition of H2O2 to CSF provoked weak HO
•
generation. This represents an inevitable consequence
of the presence of redox-active metals in normal CSF
(copper 0.25 µM, iron 0.8 µM).24 Such baseline
Fenton system activity may have some constructive
32 Redox Report 2010      Vol 15      No 1
Spasojević et al. Bioavailability and catalytic properties of copper and iron for Fenton chemistry in human cerebrospinal fluid
Figure 2 Characteristic EPR spectra of BMPO adducts in the
CSF with: (A) Cu2+ (100 µM) and H2O2 (1 mM); (B) Fe3+
(100 µM) and H2O2 (1 mM). Grey: the simulation of
spectrum composing of BMPO/OH and BMPO/C
signals
Figure 3 Ligand modulation of the catalytic activity of
metals. Characteristic EPR spectra of BMPO
adducts obtained in the CSF with: (A) Cu2+-EDTA
(100 µM) and H2O2 (1 mM); (B) Fe3+-EDTA (100 µM)
and H2O2 (1 mM); (C) Cu2+ (100 µM), DDC (500 µM)
and H2O2 (1 mM); (D) Fe3+-EDTA (100 µM), DDC (500
µM) and H2O2 (1 mM)
role in the maintenance of redox equilibrium (e.g. by
removing excess H2O2). Free copper as well as weakly
chelated iron, in the presence of H2O2, provoke an
increase in the production of HO• in CSF. As we
added the oxidised form of copper (Cu2+), it had to be
reduced to the cuprous form (Cu+) in order to
participate in the Fenton mechanism. Ascorbate,
glutathione and other reducing agents present in the
CSF may be responsible for this. In addition, Cu2+ is
susceptible to H2O2-mediated reduction via the
previously proposed reactions:25
Cu2+ + H2O2→ Cu
+H2O
• + H+
Cu+H2O
• + H2O2→ Cu
+ + HO• + O2 + H2O
Cu+ + H2O2→ Cu
2+ + HO• + OH–
Summary: 
Cu2+ + 3H2O2→ 2HO
• + O2 + 2H2O + Cu
2+
This mechanism could account for significant
deleterious effects of the Cu2+ + H2O2 system in
biological structures compared to the corresponding
system containing iron.26,27 The best illustration of the
reactivity of free copper is the fact that its intracellular
concentration under normal conditions is restricted to
only one ion per cell.28
Iron supplementation did not provoke HO•
generation. Under physiological conditions, iron is
only slightly soluble as it tends to form precipitates
with ions such as OH– and inorganic phosphates.29
However, iron and copper can be catalytically
interlinked in CSF. It has been previously shown that
Cu+ can reduce Fe3+.20,25 Therefore, iron could
facilitate copper-induced HO• generation via the
reactions:
Cu+ + Fe3+→ Cu2+ + Fe2+
Fe2+ + H2O2→ Fe
3+ + HO• + OH–
This we observed in the binary catalytic system in
the CSF. HO• generated in CSF can react with proteins
and carbonate ions forming carbon-centred radicals
which represent very dangerous reactive species due to
their long life-time and specificity for the enzyme
active centres containing metals (e.g. those of
superoxide dismutase or glutathione peroxidase).30
Iron itself  becomes redox-active in the CSF when
partially chelated.31 This was illustrated by using
EDTA as a model of physiological low molecular
weight iron complexes.31 Various compounds present
in CSF may, in a similar way to EDTA, bind and
stabilise iron in vivo. It is known that ADP and ATP
complex Fe3+ and promote its Fenton-related
reactivity.32 Nitric oxide (NO) is also capable of
increasing iron solubility via the formation of DNIC
(dinitrosyl iron complexes). The sum of nitrites and
nitrates, as end products of NO, is increased in
Parkinson’s disease, Alzheimer’s disease4 and ALS,33
which correlates with higher NO production during
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Figure 4 Relative generation of BMPO/OH adducts in the CSF. The intensities were established using the spectral simulations
of corresponding EPR signals obtained in 10 different CSF samples.
neurodegeneration. The opposite effects of complex
formation on copper reactivity could be explained by
the fact that Cu2+ reduction is presumed to proceed by
reducing agent polarisation,34 a process that cannot
proceed if  only a single labile position remains at the
metal centre.35
Therapeutic strategies using metal chelators have
had some success in altering the progression of
symptoms of Alzheimer’s disease, Parkinson’s disease
and other neurodegenerative diseases.36 Our results
indicate that copper and iron require different
approaches to be developed in order to prevent the
Fenton reaction-mediated oxidative stress both in
CSF and brain tissue. The high reactivity of free
copper requires application of a strong and efficient
chelator. On the other hand, the main characteristics
of an iron sequestrant should be its ability to compete
with metal ligands naturally present in CSF. We
demonstrated that DDC was able to inhibit the pro-
oxidative activity of both free copper and weakly
chelated iron. In addition, we have recently shown that
DDC inhibits the in vitro generation of HO• in the
Fenton system with Fe2+.37 In vivo Fe-DDC2
complexes bind NO thus forming MNIC and DNIC.38
In this way, DDC may remove iron and any excess NO
from the CSF or nervous tissue during neuro -
degeneration. Such permissive roles of DDC open the
possibility for an application of its pharmacological
form (disulfiram) in the treatment of neuro -
degenerative disorders. However, the effects of
reducing agents such as ascorbate, urate, glutathione
and dopamine present in CSF on the catalytic
properties of copper and iron should be further
examined.
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